4//SEC Filing
Englese Thomas 4
Accession 0001415889-22-009538
CIK 0001708527other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 5:05 PM ET
Size
8.9 KB
Accession
0001415889-22-009538
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-09-08+15,390→ 21,997 total - Exercise/Conversion
Restricted Stock Units
2022-09-08−15,390→ 0 total→ Class A Common Stock (15,390 underlying) - Tax Payment
Class A Common Stock
2022-09-08$7.30/sh−4,728$34,514→ 17,269 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
- [F2]Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
- [F3]The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
Related Parties
1- filerCIK 0001825799
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 5:05 PM ET
- Size
- 8.9 KB